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MS/MSAbstract Background: Inborn errors of metabolism (IEM) have a high morbidity and mortality in
neonates. Unfortunately, there is no nationwide neonatal screen in Egypt, so several cases may be
missed.
Objective: The aim of this work was to detect the prevalence of IEM among neonates with sus-
pected IEM, and to diagnose IEM as early as possible in order to minimize morbidity and mortality
in high risk neonates.
Subjects and methods: This prospective study included 40 neonates admitted to the Elmahalla
General Governmental Hospital Neonatal Intensive Care Unit (NICU) with sepsis like symptoms
(lethargy, hypoactivity, poor suckling, and poor crying), convulsions, persistent metabolic acidosis,
persistent vomiting, or previous sib death of unidentiﬁed cause (neonates with suspected IEM). All
included patients were subjected to detailed full history, through clinical examination, laboratory
investigations, and metabolic screening by tandem mass spectrometry (MS/MS). Other investiga-
tions for IEM including lactate, ammonia, and galactose 1 phosphate levels in the blood, as well
as organic acids in urine were done according to each case.
Results: 13 patients (32.5%) were diagnosed as having IEM, 7 of them (53.8%) had urea cycle
defect, 2 (15.4%) had maple syrup urine disease, while methylmalonic acidemia, fatty acid oxidation
defect, mitochondrial disease, and galactosemia were diagnosed in one patient each (7.7%). Out of
these patients, 12 patients (30%) were discharged from NICU after therapy, and one patient
(2.5%) died (the one who had mitochondrial disease). Two patients were diagnosed as diseases other
than IEM, one had hyperinsulinism and another one had congenital myopathy, while 2 patients were
proved to be normal. Five patients (12.5%) were suspected to have IEM (tyrosinemia, mitochondrial
166 R.M. Shawky et al.disease, organic acidemia) 4 of themdied before ﬁnal diagnosis, and one transferred to anotherNICU.
There was a signiﬁcant difference between diagnosed and undiagnosed patients as regards history of
sibling death (p= 0.012), plasma ammonia level (p= 0.002), and discharge fromNICU (p= 0.000).
Conclusion: IEM represent a high percent (32.5%) of neonates who had sepsis like symptoms, and
when diagnosed, patients showed marked improvement after therapy. IEM should be considered in
differential diagnosis of the sick neonates, and investigations, andmanagement should be started rap-
idly to decrease morbidity, and mortality till nationwide screen for IEM is applied in Egypt.
 2015 Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inborn errors of metabolism (IEM) are a highly heterogeneous
group of genetic conditions and represent a relevant cause of
morbidity and mortality in the pediatric population. IEM,
which are individually rare but collectively numerous, are
well-recognized entities of the generic class of ‘‘rare’’ diseases.
Since the ﬁrst descriptions by Garrod at the beginning of the
20th century, several hundred new disorders have been deﬁned,
as new biochemical and molecular diagnostic tools became
available [1].
The early diagnosis of IEM by laboratory-based mass
screening is a type of preventive medicine. However, several
factors restrict the range of IEM that can be screened for,
and the number of people to whom it can be made available.
Ideally, extension of mass screening of neonates for a clinically
signiﬁcant IEM is a desirable strategy. Tandem mass spec-
trometry (TMS) is a powerful and effective diagnostic tech-
nique and has been proposed as a means to realize this aim.
Its main advantages are improved accuracy, sensitivity and
speciﬁcity over existing methods, and its suitability for cost-
effective multidisease IEM mass screening [2].
The aim of this work was to detect the prevalence of IEM
among neonates with suspected IEM, and to diagnose IEM as
early as possible in order to minimize morbidity and mortality
in high risk neonates.
2. Subjects and methods
This study included 40 neonates (31 males and 9 females)
admitted to the Elmahalla General Governmental Hospital
Neonatal Intensive Care Unit (NICU) with sepsis like symp-
toms (lethargy, hypoactivity, poor suckling, and poor crying),
as well as convulsions, persistent metabolic acidosis, persistent
vomiting, or history of previous sib death of unidentiﬁed
cause, or clinical deterioration in a previously healthy neonate.
The study was conducted at the Genetics Unit, Children’s Hos-
pital, Ain Shams University, Cairo, Egypt.
The patients’ age ranged from 3 to 25 days. All included
patients were subjected to detailed full history with special
emphasis on age, sex, gestational age, antenatal and perinatal
history, symptoms of the patient, age of onset of symptoms,
relation of symptoms to feeding, similar cases in the family,
parental consanguinity, and previous neonatal death. Through
clinical examination, laboratory investigations including com-
plete blood count (CBC), C reactive protein (CRP), electro-
lytes (Na, K, Ca), blood gases, pH, and metabolic screening
by tandem mass spectrometry (MS/MS) were done to detect
aminoacid and acyl carnitine proﬁle. Other investigations forIEM including plasma lactate, ammonia level, and organic
acids in urine were done according to each case. Galactose 1
phosphate level estimation was done in one patient.
2.1. Statistical methodology
Analysis of data was performed using standard computer pro-
gram statistical package for social sciences (SPSS) 13.0 for
windows (SPSS Incorporation, USA). P< 0.05 was consid-
ered signiﬁcant.
3. Results
Thirty-one neonates were males (77.5%). Family history of
paternal consanguinity and sibling health of the patients is pre-
sented in (Table 1). The weight of the patients ranged from 1.2
to 3.8 kg, with a mean of 2.65 kg ± 0.61 kg. All patients were
normal at birth with no complications during delivery, then
they started to develop symptoms at an age ranged from 1
to 10 days with a mean of 3.35 ± 2.155 days. The main pre-
senting symptoms were sepsis like symptoms in 25 patients
(62.5%) (Table 2). Neurological examination was normal in
12 patients (30%).
Aminoacid and acyl carnitine proﬁle (metabolic screen) by
tandem mass spectrometry was abnormal in 13 patients
(32.5%), while organic acids in urine showed methyl malonic
acidemia in 1 patient (2.5%). The investigations done are
shown in Table 3.
Thirteen patients 13/40 (32.5%) were diagnosed as having
IEM, out of them 12/13 (92.3%) patients were discharged from
NICU after therapy. Urea cycle defect was the commonest
IEM diagnosed in 7/13 (53.8%), followed by MSUD in 2/13
(15.4%). 18/40 patients (45%) were not diagnosed as 12/18
(66.7%) of them died and 6/18 (33.3%) of them discharged
from NICU before diagnosis. Data are shown in Table 4.
There was no signiﬁcant difference between diagnosed and
undiagnosed patients as regards sex of the patient, age of onset
of symptoms, consanguinity, and type of the presenting symp-
tom. There was a statistically signiﬁcant difference between
diagnosed and undiagnosed patients as regards family history
of sib death (p= 0.012), plasma ammonia level (p= 0.002),
metabolic screen (aminoacid and acyl carnitine proﬁle)
(p= 0.045), and fate of the patients (p= 0.000).
Seven patients (53.8%) (out of 13 who diagnosed as IEM)
had a urea cycle defect. They were full term, and their weight
ranged from 1.700 to 3.1 kg. All were normal at birth, and
then they started to develop hypoactivity, poor suckling,
and poor crying at age ranged between 2 and 7 days. Two
of them developed convulsions. Consanguinity of the parents
Table 1 Family history of the patients.
Studied patients
(n= 40)
Consanguinity Positive 17 (42.5%)
Negative 23 (57.5%)
Sibling health No sib death 24 (60%)
Sib death 15 (37.5%)
Sib death (diagnosed with IEM) 1 (2.5%)
IEM: inborn errors of metabolism, n: number.
Selective newborn screening 167was positive in 3 patients (42.9%). Clinical examination
showed hypoactivity, hypotonia, and hyporeﬂexia. Labora-
tory investigations showed that serum ammonia was signiﬁ-
cantly high in all cases (ranged from 200 to 330 mcg/dL),
with no acidosis, and normal extended metabolic screeningTable 3 Investigations of inborn errors of metabolism of the studie
Investigation Result
Metabolic screen Normal
Speciﬁc ﬁnding
Ammonia Normal
Border line elevation
High
Not done
Lactate High
Not done
ABG with anion gap Normal
Acidosis with high anio
Acidosis, anion gap no
Organic acids in urine Speciﬁc ﬁndings
Normal
Not done
n: number; ABG: arterial blood gas.
Table 2 The presenting symptoms of the patients.
Main presentation Associated symptoms
Sepsis like symptoms –
Convulsions
Vomiting
Previous sib death (? IEM)
Metabolic acidosis
Acidosis, previous sib deat
Convulsions –
Vomiting
Persistent metabolic acidos
Previous sib death (? IEM)
Persistent vomiting
Persist metabolic acidosis –
Vomitingtest. Management was started and all were discharged from
NICU for follow up.
Two patients (15.4%) had maple syrup urine disease
(MSUD). They were full term males. Their ages were 8, and
15 days old. Their weights were 2.760 and 3.160 kg respective-
ly. Both were of consanguineous parents. They presented with
poor suckling, poor activity and spasticity at age of 2 days.
Clinical examination showed poor moro reﬂex, opisthotonus
position, fair chest air entry and mild intercostal retraction.
Laboratory ﬁnding showed acidosis with high anion gap.
The extended metabolic screening test showed high leucine,
isoleucine, valine, leucine:phenylalanine ratio and leucine:ala-
nine ratio which are diagnostic for MSUD. Speciﬁc manage-
ment was started which led to improvement of the patients
who were discharged from NICU for follow up.
Another patient (2.5%) aged 18 days, was diagnosed as lac-
tic acidosis (probably due to mitochondrial disorder). He was a
full term male, 2nd in order of birth of non consanguineousd patients.
n %
27 67.5
13 32.5
3 7.5
5 12.5
13 32.5
19 47.5
35 87.5
5 12.5
20 50
n gap 6 15
t done 14 35
1 2.5
4 10
35 87.5
Studied patients (n= 40)
15 (37.5%)
3 (7.5%)
3 (7.5%)
2 (5%)
1 (2.5%)
h (? IEM) and vomiting 1 (2.5%)
25 (62.5%)
6 (15%)
1 (2.5%)
is 1 (2.5%)
8 (20%)
3 (7.5%)
2 (5%)
1 (2.5%)
1 (2.5%)
2 (5%)
Table 4 Final diagnosis and fate of the patients.
Final diagnosis n Percent Fate
Died % Discharged %
IEM UCD 7 53.8 0 7
MSUD 2 15.4 0 2
Mitochondrial 1 7.7 1 100 0
MMA 1 7.7 0 1
Galactosemia 1 7.7 0 1
FAOD 1 7.7 0 1
13 32.5 1 7.7 12 92.3
Other diagnosis Hyperinsulinism 1 50 0 1
Congenital myopathy 1 50 0 1
2 5 0 2
Normal 2 5 0 2
Suspected IEM Organic acidemia 3 60 2 66.6 1 33.4
Tyrosinemia 1 20 1 100 0
Mitochondrial 1 20 1 100 0
5 12.5 4 80 1 20
Undiagnosed* 18 45 12 66.7 6 33.3
Total 40 17 42.5 23 57.5
IEM: inborn errors of metabolism, n: number, UCD: urea cycle defect, MSUD: maple syrup urine disease, MMA: methylmalonic acidemia,
FAOD: fatty acid oxidation defect.
The bold numbers indicate the total number of each ﬁnal diagnosis.
* Discharged on parent request.
168 R.M. Shawky et al.parents. The mother had gestational diabetes. His weight was
2.9 kg at 18 day. He had persistent metabolic acidosis which
started at the age of 5 days. There was no family history of
the same condition. Clinical examination showed poor activ-
ity, and hepatomegaly. Laboratory ﬁndings showed impaired
liver functions tests, high lactate (78.3 mg/dL) repeatedly,
and persistent metabolic acidosis with high anion gap.
Extended metabolic screening showed high free carnitine.
Magnetic resonance spectroscopy (MRS) on the brain was
arranged but unfortunately the patient died.
There was also one patient (2.5%) diagnosed with methyl
malonic acidemia at 25 days. He was a full term male, 2nd in
order birth of 1st cousin consanguineous parents. His weight
was 3 kg. He had persistent vomiting and acidosis which
started at the age of 5 days. There was a history of sib death
at the neonatal period without diagnosis. Clinical examination
showed hypotonia. Laboratory investigations showed high
ammonia and metabolic acidosis. Extended metabolic screen
showed high propionyl carnitine (C3), and C3:C2 ratio.
Organic acids in urine showed high methyl malonic acid which
is consistent with the diagnosis of methyl malonic acidemia.
Speciﬁc management was started and the patient improved
and discharged from NICU for follow up.
Another patient (2.5%) had fatty acid oxidation defect. He
was a full term male aged 10 days, 4th in order of birth of non
consanguineous parents. His weight was 2.6 kg, and he had
hypoactivity at the age of 2 days. Family history showed pre-
vious 3 sibs death. The 1st was a female died at birth due to
suspected obstructed labor, the 2nd was a female who had
hypo activity, poor suckling, metabolic acidosis and high
ammonia which started at 2 days old, and she died at 17 days,
and the 3rd was a male who had persistent metabolic acidosis
which started at 2 days old, and he died at 7 days old. In ourpatient laboratory ﬁndings showed persistent hypoglycemia,
border line elevation of ammonia, no acidosis and extended
metabolic screen showed high C6,C8,C10 consistent with the
diagnosis of medium chain acyl CO-A dehydrogenise deﬁ-
ciency (MCAD). He started management and discharged from
NICU for follow up.
Another patient (2.5%) had galactosemia. She was a full
term female aged 23 days, 5th in order birth of 1st cousin con-
sanguineous parents. Her weight was 3 kg. She was admitted
to NICU at birth for respiratory distress and she was on
mechanical ventilator. After improvement she was weaned
from ventilator and started normal feeding, but she deterio-
rated, and started to develop jaundice, and hematemesis. Fam-
ily history showed that her 1st sib was a healthy female, the
2nd sib was a premature male with imperforate anus who died
soon after birth, the 3rd sib was a female who developed jaun-
dice & hematemesis then died without diagnosis at 14 days,
and the 4th sib was a female who developed epilepsy at the
age of 11 months and now she is on depakine, otherwise she
is normal. Clinical examination showed jaundice. Laboratory
ﬁndings showed high liver function tests, direct hyperbilirubi-
nemia, and high alpha-fetoprotein. There was no acidosis.
Extended metabolic screen showed high citrulline and methio-
nine for correlation with clinical picture. Non glucose reducing
substance in urine was detected, and galactose 1 phosphate
level was high which is consistent with the diagnosis of galac-
tosemia. Management was started and she was discharged
from NICU for follow up.
In our study there were also 5 patients (12.5%) who were
suspected to have IEM but 4 of them (80%) died and one
(20%) discharged from NICU as requested by the parents
before completing their conﬁrmatory investigations. Three
patients of them (7.5%) were suspected to have organic acide-
Selective newborn screening 169mia. The 1st patient was a full term male, 1st in order of birth
of 1st cousin consanguineous parents. His weight was 3 kg. He
presented with poor activity, poor suckling, and convulsions at
the age of 3 days. Laboratory investigations showed persistent
metabolic acidosis, and extended metabolic screen showed
High C16-Carnitine (6.35 lmol/L), C6-Carnitine (0.41 lmol/
L), C5-DC (0.5 lmol/L), C4-OH (C3-DC) (1.78 lmol/L),
and high C3 DC. Organic acidemia was suspected and organic
acids determination in urine was recommended, however the
patient died before completing the investigations.
The 2nd patient was a preterm female, 1st in order of birth
aged 11 days, of non consanguineous parents. Her weight was
1.48 kg, and she had poor activity at the age of 3 days. Her
twin died at the age of 5 days old by the same presentation.
Clinical examination showed hypotonia, hypoactivity and
dehydration. Laboratory investigations showed persistent met-
abolic acidosis with high anion gap. Extended metabolic screen
showed high free carnitine (540 lmol/L), C4-Carnitine
(0.840 lmol/L), C6-Carinitine (0.290 lmol/L), for correlation
with clinical picture. Organic acids in urine and lactate were
recommended, however the patient died before completing
the investigations.
The 3rd patient was a preterm male aged 5 days, 1st in
order of birth, of non consanguineous parents. His weight
was 2.200 kg. He presented with poor activity at the age of
1 day. Clinical examination showed hypotonia. Laboratory
ﬁndings included high ammonia, metabolic acidosis with high
anion gap, and extended metabolic screen showed high C6, C4.
Organic acids in urine and lactate were recommended, but the
patient discharged from NICU as requested by the parents,
and lost follow up.
Another patient (2.5%) was suspected to have tyrosinemia.
He was a full term male aged 17 days, 3rd in order of birth, of
1st cousin consanguineous parents. Her weight was 3.6 kg. She
presented with poor activity and poor suckling at the age of
4 days. Clinical examination showed high respiratory rate,
hypoactivity and hepatomegaly. Laboratory investigations
showed low platelet count, high liver function tests, direct
hyper bilirubinemia, metabolic acidosis, negative non glucose
reducing substance in urine, and extended metabolic screen
showed high tyrosine level. Succinyl acetone in urine was rec-
ommended as tyrosinemia was suspected. The patient died
before doing the test.
There was another patient (2.5%) with suspected mitochon-
drial disorder. He was full termmale aged 9 days, 1st in order of
birth, of 1st cousin consanguineous parents. His weight was
2.85 kg. He presented with poor activity, poor suckling and
vomiting at the age of 4 days. Clinically he showed hypoactiv-
ity. Laboratory investigations showed high ammonia, high lac-
tate, acidosis and normal organic acids in urine. Extended
metabolic screening did not show speciﬁc ﬁndings. CSF lactate
or repeat blood lactate, and magnetic resonance spectroscopy
(MRS) were recommended, however the patient died before
doing the test.
In our study there were also 2 patients (5%) aged 12, and
21 days who presented with sepsis like symptoms, persistent
vomiting and persistent metabolic acidosis, but the investiga-
tions and metabolic screening did not prove IEM. While other
investigations proved other diagnosis. One of the patients was
diagnosed as a case of hyperinsulinism. He was a full term
male, 1st in order of birth, of non consanguineous parents.
His weight was 2.9 kg. He presented with poor suckling andpoor activity at the age of 3 days. His twin had the same symp-
toms and died at the age of 10 days without diagnosis. Labo-
ratory ﬁndings showed persistent hypoglycemia. Ammonia
showed border line elevation, and no speciﬁc ﬁndings were
detected in the extended metabolic screening. Insulin level
was high during hypoglycemia. Management was started and
the patient discharged from NICU.
The other patient was diagnosed as a case of congenital
myopathy. He was a full term male, 3rd in order of birth, of
1st cousin consanguineous parents, his weight was 3.800 kg.
He had poor activity, persistent vomiting, and persistent met-
abolic acidosis at the age of 2 days. Family history showed a
previous sib death at 1 month old by the same symptoms with-
out reaching a deﬁnite diagnosis. Clinical examination showed
hypoactivity, hypotonia, weak grasping reﬂex, absent deep
tendon reﬂexes. EMG showed the presence of low amplitude,
polyphasic, brief duration potential with voluntary contrac-
tions, and normal nerve conduction velocity. He was dis-
charged from NICU for follow up.
In our study there were also 2 neonates admitted to NICU
under observation as the parents had previous infant deaths at
the neonatal period of unknown cause. They did not develop
any manifestations, and their laboratory ﬁndings did not show
any abnormality and they were discharged. Both of them were
normal.
We did not reach a speciﬁc diagnosis in 18/40 patients
(45%) as 12 patients died early and 6 were discharged
from NICU and/or transferred to other NICU as requested
by the parents and lost follow up before completing their
investigations and their EMS did not show speciﬁc
ﬁndings.4. Discussion
This study included 40 neonates with suspected diagnosis of
inborn errors of metabolism (IEM) depending on symptoms
like poor suckling, poor crying, hypoactivity, lethargy, convul-
sions, persistent metabolic acidosis, persistent vomiting, and
previous neonatal deaths in the family without deﬁnite diagno-
sis or with suspected IEM. Investigations including ammonia
and lactate in blood, as well as organic acids in urine were
done according to the suspected diagnosis. Screening for
IEM was done by MS/MS. IEM was proved in 13 patients
(32.5%).
The introduction of MS/MS into neonatal screening has
enabled the screening of conditions that might otherwise have
been missed, and thus believed to be extremely rare [3]. This
technique has signiﬁcantly improved the efﬁcacy of neonatal
screening programs, demonstrating the importance of early
identiﬁcation and treatment of infants with disorders that
would otherwise go unrecognized, before irreversible clinical
damage occurs [4].
In this study we found that IEM was diagnosed in 13/40
(32.5%) of neonates presented with sepsis like symptoms, con-
vulsions, persistent metabolic acidosis, and persistent vomit-
ing, or previous sib deaths. EMS showed speciﬁc ﬁndings in
12/40 patients (30%).
In Egypt, as there is no nationwide newborn screening,
variable percentages of IEM were found in different studies
according to the type of selection of patients. In a study done
by Shawky et al. (2001) they screened mentally retarded
170 R.M. Shawky et al.children by paper chromatography, ferric chloride test, and
nitroprusside test for plasma and urine. 51/450 (11.3%) were
diagnosed to have IEM [5]. In another extended metabolic
screen done in 2004 on 232 cases (44 neonates and 187 chil-
dren) with symptoms suggestive of IEM abnormal results were
detected in 22.73% of neonates [6]. Also IEM were diagnosed
in 20/50 infants and children (40%) who were suspected to
have IEM [7]. Also in another study the incidence of IEM
was 2.3% (11/486) in screening of neonates admitted to NICU
for any cause not speciﬁcally for IEM in a period of 6 months
[8]. IEM were also conﬁrmed in 6% (203/3380) of children sus-
pected to have IEM [9]. The high incidence of IEM in our
study compared to other studies is due to that we selected neo-
nates with suspected IEM, not all admitted to NICU.
In Brazil, a study on neonates presenting with hypoglyce-
mia (glucose less than 40 mg/dl), metabolic acidosis (fall of
0.15 in pH and fall of 10 mEq/l in bicarbonate), jaundice, dif-
ﬁculty in gaining weight (weight gain <10 g over four consec-
utive days, despite a caloriﬁc offer >100 cal/kg), diarrhea,
vomiting, hepato- and/or splenomegaly, cataracts, apnea, con-
vulsions, and hypo- or hypertonia. They diagnosed 64 (63.3%)
patients out of 101. Most of the positivity was due to
transitory metabolic alterations of the newborn. Others were
mucopolysaccharidoses, tyrosinemia type I, non-ketotic hyper-
glycinemia, Alpers’ Syndrome and pyruvate dehydrogenase
complex deﬁciency [10].
The incidence of IEM was higher in de Oliveira et al. (2001)
[10] (63.5%), than in our study (32.5%) which may be related
to the wider range of symptoms they included in their study,
different methods of investigations used (the cetyltrimethyl
ammonium bromide test, utilized for the detection of glycos-
aminoglycans in urine and the nitrosonaphthol test speciﬁc
for the detection of tyrosine and an excess of its metabolites
in urine) in their study, versus MS/MS in ours, so the detection
method will affect the rate and type of IEM detected in the
screening method. Also a high number of preterm infants were
included in their study, and so their results revealed several
cases with transitory neonatal tyrosinemia. Transient neonatal
tyrosinemia is believed to be the most common alteration in
the metabolism of amino acids in human beings, with an inci-
dence of 10% among full-term newborns and between 30%
and 50% among premature newborns [11].
In China, a study was done by Huang et al. 62 IEM patients
(0.56%) were diagnosed out of 11,060 symptomatic patients.
The age of included patients ranged from 0.04 to
168.2 months, and they presented with metabolic acidosis,
jaundice, hepatosplenomegaly, recurrent vomiting, hypoglyce-
mia, hyperammonemia, mental retardation of unknown cause,
language retardation, seizures and unconsciousness. Only one
patient had consanguineous parents [12]. The main difference
between China study and our study was the age of the patients
as they included older patients, with wider presenting symp-
toms, while our study included neonates only. Consanguinity
rate was also high among included neonates.
Two studies were done in Korea in 2003, and 2005 respec-
tively to screen for IEM. Blood spots of newborns were col-
lected between 48 and 72 h after birth, and children between
1 month and 18 years of age presented with symptoms of
IEM. They diagnosed IEM in 35 (0.079%) out of 44,300 in
one study [13], and 20 (0.29%) out of 6795 in the other study
[14]. In a Chinese study, which screened 129,415 neonates,
revealed 23 (0.02%) neonates having IEM [15]. Also in a Ger-man study, among 250,000 neonates revealed 106 (0.04%) neo-
nates with IEM [16]. Also a North Carolina study reported 219
(0.02%) out of 944,078 patients in neonatal screening over
20 years [17].
The variation in detection rates of IEM in different coun-
tries is not surprising, considering the different screening crite-
ria for IEM used in different countries, sample size and
consanguinity rate in the country. There was a low incidence
of IEM in these studies compared to our study as they screened
all neonates, also high incidence of consanguineous marriage
in our country may be another factor to explain the high inci-
dence of IEM in our study [18].
In our study, out of 13 patients who had IEM, 7 patients
(53.8%) had consanguineous parents. This could not be
explained only by the high consanguinity rate in Egypt which
reaches up to 35.3% [18], but also by the fact that most IEM
diagnosed in the patients are autosomal recessive which
increase in incidence by consanguineous mating because rela-
tives more often share abnormal genes inherited from a com-
mon ancestor and most IEMs are autosomal recessive
disorders. Hence a history of parental consanguinity and/or
sibling deaths should increase the suspicion of IEM [19].
So the initial step in the evaluation of any sick neonate and
clearly the most important one is a thorough clinical assess-
ment including a positive family history of consanguinity or
sib death [20].
In our study, 12 males (92.3%) and one female (7.7%) were
diagnosed as cases of IEM. The male predominance can be
explained by the predominance of urea cycle defects in our
patients {7 out of 13(53.8%)}, most probably carbamyl syn-
thase or ornithine transcarbamylase deﬁciency. The later is
inherited as X linked disease which usually manifests in males.
In our study, the most common IEM was urea cycle defect
in 7/13 then MSUD in 2/13, followed by MMA, and MCAD
in 1/13 each. In contrast to other studies done in Egypt, a gen-
eral screening program including 2000 infants was done in
2001 from plasma samples. Transient neonatal tyrosinemia
was detected in 0.05% and generalized aminoacidemia in
0.05%, and in another selective screening study on children
with mental retardation revealed that phenyl ketonuria was
the commonest IEM (40/51 cases 40%), followed by general-
ized aminoaciduria (4/51 cases 7.84%) [5]. In another study
organic acidemias were detected in 13.63%, aminoacidopa-
thies in 4.55%, fatty acid oxidation defects in 4.55% of neo-
nates. In children abnormal results were also detected in
8.56% of children, including aminoacidopathies in 5.88%,
organic acidemias in 1.07%, cystic ﬁbrosis, congenital adrenal
hyperplasia and congenital hypothyroidism in 1.61%, PKU
was detected in 6.48% of children with MR, and MSUD in
10% of children with convulsions [6]. PKU was the common-
est IEM detected in another study [7]. Aminoacidopathies in
127/203 (62.6%), mainly PKU in 100/203 (49.3%), were the
most encountered IEM, followed by organic acidemias in 69/
203 (34%) in another study [9]. MSUD was the commonest
IEM in 5/11 (45.5%) patients, followed by non ketotic hyper-
glycinemia in 2/11 (18.2%), then tyrosinemia I in 1/11 (9.1%),
MMA in 1/11 (9.1%), glutaric aciduria in 1/11 (9.1%), and
isovaleric acidemia in 1/11 (9.1%) in another study [8].
The variation in the commonest cause of IEM in these stud-
ies is due to variation in investigations done (ammonia and lac-
tate were added in our study), and age variation of the
patients. PKU was not found in our cases, which is expected
Selective newborn screening 171as it does not have manifestations in newborn period, and it
usually presents later in life with mental retardation.
In China, the most common IEM diagnosed was aminoac-
idopathy, PKU, followed by maple syrup urine disease
(MSUD) [12]. Also in Taiwan in nationwide survey of new-
born screening revealed that the most common IEM was a
defect in phenylalanine metabolism then MSUD [21]. In North
Carolina, the most common IEM was MCAD (medium-chain
acyl-CoA dehydrogenase) deﬁciency, PKU, followed by
MMA, then MSUD [17].
The patients who were diagnosed by a speciﬁc diagnosis
and so speciﬁc management for their diseases was initiated
has improved and discharged from NICU, while patients
who were not diagnosed mostly died. This leads to a highly sig-
niﬁcant difference in the outcome of patients diagnosed and
not diagnosed. So reaching a diagnosis, starting effective spe-
ciﬁc management is highly critical in improvement of patients.
In our study the most common symptom was sepsis like
symptoms (poor feeding, poor activity and poor crying) in
25/40 (26.5%) which was in agreement with Clarke who
advised to consider inborn errors of metabolism at the same
time as common acquired conditions, such as sepsis [2]. The
other common presenting features among our cases included
convulsions in 8/40 (15%). This came in agreement with Lund
et al. who reported that the predominant symptoms in neo-
nates suggesting the possibility of metabolic disorders were
convulsions and lethargy [22].
In our study there was a highly signiﬁcant frequency of
hyperammonemia in 10 patients (66.7%) who were diagnosed
with IEM, 7 had urea cycle defect, 2 had MSUD and 1 had
MMA. The main presentation of them was lethargy, poor
feeding, suckling and crying, then convulsions, persistent
vomiting and acidosis. This means that serum ammonia should
be done for every neonate presented by these symptoms, or
suspected to have IEM.
From this study we conclude that IEM represent a signiﬁ-
cant cause for sick neonates in NICU, and it should be consid-
ered in the differential diagnosis of any sick neonate.
Investigations for IEM should be done routinely in NICU
for neonates, until nationwide newborn screening can be
applied in Egypt, and they should be done collectively not
one by one in order to improve survival and decrease mortality
and morbidity of patients.Conﬂict of interest
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